Drug intelligence / Profile preview

methyl 4-deoxy-4-fluoro-D-glucopyranoside

Development stage
Unknown
Lead developer
University of California, Los Angeles
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Methyl 4-deoxy-4-fluoro-D-glucopyranoside is a synthetic, fluorinated methyl-glycoside that serves as a high-affinity, selective substrate for the **Sodium/glucose cotransporter 1 (SGLT1)** and, to a lesser extent, **Sodium/glucose cotransporter 2 (SGLT2)**. Unlike glucose, which is transported by both SGLTs and facilitated diffusion (GLUT) transporters, this compound is specifically recognized by active transport systems and exhibits negligible affinity for GLUT transporters such as GLUT1 and GLUT2. This high selectivity makes it an invaluable diagnostic tool and molecular probe for studying active sugar transport in physiological systems, particularly in the small intestine and kidneys. When synthesized using the radioactive isotope fluorine-18 ([18F]Me-4FDG), it is utilized in **Positron Emission Tomography (PET)** imaging to non-invasively quantify SGLT expression and activity. The development of this agent as a clinical imaging probe has been primarily led by researchers at the **University of California, Los Angeles (UCLA)**, with applications targeting oncology—where SGLT proteins are often overexpressed—and metabolic research involving diabetes mellitus.

Other names
Methyl 4-fluoro-4-deoxy-D-glucopyranosideMethyl4-fluoro-4-deoxy-D-glucopyranosideMethyl-4-fluoro-4-deoxy-D-glucopyranosideMethyl 4-fluoro-4-deoxy-alpha-D-glucopyranosideMethyl4-fluoro-4-deoxy-alpha-D-glucopyranosideMethyl-4-fluoro-4-deoxy-alpha-D-glucopyranosidealpha-Methyl-4-deoxy-4-fluoro-D-glucopyranosidealpha-Methyl4-deoxy-4-fluoro-D-glucopyranosidealpha-Methyl 4-deoxy-4-fluoro-D-glucopyranosideMethyl 4-deoxy-4-fluoro-D-glucosideMethyl4-deoxy-4-fluoro-D-glucosideMethyl-4-deoxy-4-fluoro-D-glucoside
02

Targets

SGLT2 (Sodium-glucose cotransporter protein subunit 2)SLC5A1 (Sodium Glucose Cotransporter 1)

Beyond the preview

Go deeper on methyl 4-deoxy-4-fluoro-D-glucopyranoside.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methyl 4-deoxy-4-fluoro-D-glucopyranoside.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call